Embedded Files
Is the questionnaire available in multiple languages?
Is the questionnaire available in multiple languages?
Yes. Questionnaire has been professionally translated and reviewed by field experts for Arabic, Basque, Catalan, Dutch, French, Galician, German, Hindi, Italian, Japanese, Korean, Mandarin Chinese, Persian, Portuguese, Spanish. Covering the most widely spoken languages. All translations were reviewed for conceptual accuracy by field experts.
Yes. Questionnaire has been professionally translated and reviewed by field experts for Arabic, Basque, Catalan, Dutch, French, Galician, German, Hindi, Italian, Japanese, Korean, Mandarin Chinese, Persian, Portuguese, Spanish. Covering the most widely spoken languages. All translations were reviewed for conceptual accuracy by field experts.
Is there a digital version of the questoinnaire available?
Is there a digital version of the questoinnaire available?
In addition to a paper-and-pencil version, digital implementations are available via Qualtrics and SoSci Survey. A REDCap-compatible instrument file will be made available via OSF to support standardized data collection across research sites.
In addition to a paper-and-pencil version, digital implementations are available via Qualtrics and SoSci Survey. A REDCap-compatible instrument file will be made available via OSF to support standardized data collection across research sites.
Can the questionnaire be used repeatedly across sessions?
Can the questionnaire be used repeatedly across sessions?
Yes. The NIBS-SES was developed for repeated, session-by-session administration and is suitable for routine safety monitoring across multiple sessions.
Yes. The NIBS-SES was developed for repeated, session-by-session administration and is suitable for routine safety monitoring across multiple sessions.
Does the NIBS-SES distinguish between Acute vs. delayed side effects?
Does the NIBS-SES distinguish between Acute vs. delayed side effects?
Yes. The instrument distinguishes between sensations or effects occurring during stimulation and those occurring between sessions.
Yes. The instrument distinguishes between sensations or effects occurring during stimulation and those occurring between sessions.
How was the NIBS-SES developed?
How was the NIBS-SES developed?
Development combined empirical session data and structured literature review of adverse effects across TMS, tES, and tUS. An initial item pool was informed by 851 TMS sessions and adverse effects reported in the literature. The questionnaire was refined using structured expert ratings. Psychometric analyses supported feasibility for repeated administration. The final NIBS-SES distinguishes effects occurring during stimulation from those occurring between sessions.
Development combined empirical session data and structured literature review of adverse effects across TMS, tES, and tUS. An initial item pool was informed by 851 TMS sessions and adverse effects reported in the literature. The questionnaire was refined using structured expert ratings. Psychometric analyses supported feasibility for repeated administration. The final NIBS-SES distinguishes effects occurring during stimulation from those occurring between sessions.
Can I freely use the NIBS-SES in my study or clinic?
Can I freely use the NIBS-SES in my study or clinic?
Yes. The NIBS-SES is open access and released under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. You may use, share, and adapt it —including for clinical or commercial contexts—provided you give appropriate credit and cite the original source.
Yes. The NIBS-SES is open access and released under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. You may use, share, and adapt it —including for clinical or commercial contexts—provided you give appropriate credit and cite the original source.
Can I adapt or translate the questionnaire?
Can I adapt or translate the questionnaire?
Yes. Adaptations and translations are permitted under CC BY 4.0. You may use, share, adapt, and translate the questionnaire for any purposes, as long as you give appropriate credit and cite the original publication/source.
Yes. Adaptations and translations are permitted under CC BY 4.0. You may use, share, adapt, and translate the questionnaire for any purposes, as long as you give appropriate credit and cite the original publication/source.
Contact
Contact
Dr. Benjamin Selaskowski
Research Associate
UK Koeln
Dr. Maximilian Kiebs
Head Brain-Stimulation Research Group
Deprtment of Psychiatry and Psychotherapy
School of Medicnie & Health Sciences
Carl von Ossietzky University of Oldenburg
Keywords / Indexing informationnon-invasive brain stimulation; NIBS; neuromodulation safety; brain stimulation side effects; adverse effects; safety monitoring; adverse event reporting; side effect questionnaire; repeated-measures questionnaire; session-by-session assessment; within-subject monitoring; TMS; transcranial magnetic stimulation; rTMS; iTBS; cTBS; theta burst stimulation; tES; transcranial electrical stimulation; tDCS; transcranial direct current stimulation; tACS; transcranial alternating current stimulation; tRNS; transcranial random noise stimulation; tUS; transcranial ultrasound stimulation; focused ultrasound neuromodulation; tolerability; acceptability; headache; scalp discomfort; tingling; pain; fatigue; dizziness; nausea; auditory effects; seizure risk; skin irritation; mood effects; cognition; clinical neurostimulation; research methods; psychometrics; harmonized instrument; cross-modality comparison
Google Sites
Report abuse